{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:58:44Z","timestamp":1787507924752,"version":"build-2736575974"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006134","name":"Foundation for Promotion of Material Science and Technology of Japan","doi-asserted-by":"publisher","award":["JP 21K09089"],"award-info":[{"award-number":["JP 21K09089"]}],"id":[{"id":"10.13039\/501100006134","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Clot-fibrinolysis waveform analysis (CFWA) is an assay used to simultaneously evaluate coagulation and fibrinolysis reactions. Although the assay detected the reaction via transmittance changes, there was no evidence that the transmittance changes indicated reactions. This study aimed to demonstrate that transmittance changes indicate coagulation and fibrinolysis reactions by detecting relative markers. CFWA was conducted using activated partial thromboplastin time (APTT) reagent and CaCl\n                    <jats:sub>2<\/jats:sub>\n                    solution with tissue-plasminogen activator (tPA); transmittance changes were monitored, and the first derivative curve was analyzed in pooled normal plasma (PNP) and factors V, VIII, IX, X, and XI-deficient plasma samples. The samples during the coagulation and fibrinolysis reactions were prepared by adding the reaction stop solution, fibrin monomer complex (FMC), fibrin\/fibrinogen degradation products (FDP), D-dimer and plasmin-\u03b1\n                    <jats:sub>2<\/jats:sub>\n                    plasmin inhibitor complex (PAP) were measured to compare the waveform with the tendencies of these markers. The fibrinolysis markers FDP, D-dimer, and PAP increased in all samples as the reaction time increased. In FMC, the value increased during the coagulation phase, decreased at the end of the phase, and increased again during the fibrinolysis phase. FMC, FDP, and D-dimers were generated from fibrin\/fibrinogen in the CFWA assay, indicating that the assay reflects coagulation and fibrinolysis reactions by monitoring transmittance.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0320111","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:32:39Z","timestamp":1755538359000},"page":"e0320111","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clarification of fibrin generation and degradation reaction processes of clot-fibrinolysis waveform in hemorrhagic disorders"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-2474","authenticated-orcid":true,"given":"Tomoko","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nukumi","family":"Tujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kouno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kurono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-0567","authenticated-orcid":true,"given":"Osamu","family":"Kumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kamioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"7","key":"pone.0320111.ref001","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.12287","article-title":"Towards standardization of clot waveform analysis and recommendations for its clinical applications","volume":"11","author":"Scientific and Standardization Committee","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0320111.ref002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1309\/W4F7892WJE6Y1W7Y","article-title":"Biphasic activated partial thromboplastin time waveform and adverse events in non-intensive care unit patients","volume":"121","author":"EY Smith","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"pone.0320111.ref003","first-page":"9","article-title":"The hidden sepsis marker: aPTT waveform analysis","volume":"100","author":"C-E Dempfle","year":"2008","journal-title":"Thromb Haemost"},{"issue":"5","key":"pone.0320111.ref004","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13266","article-title":"Clot waveform analysis using CS-2000i\u2122 distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A","volume":"23","author":"T Matsumoto","year":"2017","journal-title":"Haemophilia"},{"issue":"1","key":"pone.0320111.ref005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00001721-200201000-00002","article-title":"Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies","volume":"13","author":"Z Su","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"pone.0320111.ref006","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/bjh.16111","article-title":"A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders","volume":"187","author":"K Nogami","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"pone.0320111.ref007","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1160\/TH13-10-0870","article-title":"Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers","volume":"111","author":"M Nagler","year":"2014","journal-title":"Thromb Haemost"},{"issue":"5","key":"pone.0320111.ref008","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/jth.14002","article-title":"An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH","volume":"16","author":"M Pieters","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"3","key":"pone.0320111.ref009","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ijlh.13168","article-title":"Application of clot-fibrinolysis waveform analysis to assessment of in vitro effects of direct oral anticoagulants on fibrinolysis","volume":"42","author":"S Oka","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"pone.0320111.ref010","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12185-022-03308-w","article-title":"The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19","volume":"115","author":"T Onishi","year":"2022","journal-title":"Int J Hematol"},{"issue":"9","key":"pone.0320111.ref011","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1055\/s-0040-1713890","article-title":"A pathological clarification of sepsis-associated disseminated intravascular coagulation based on comprehensive coagulation and fibrinolysis function","volume":"120","author":"T Onishi","year":"2020","journal-title":"Thromb Haemost"},{"key":"pone.0320111.ref012","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.14022","article-title":"Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab. J","volume":"16","author":"K Nogami","year":"2018","journal-title":"Thromb Haemost"},{"issue":"5","key":"pone.0320111.ref013","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/1076029617724230","article-title":"An evaluation of the activated partial thromboplastin time waveform","volume":"24","author":"T Matsumoto","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"03","key":"pone.0320111.ref014","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1613023","article-title":"The utility of activated Partial Thromboplastin Time (aPTT) clot waveform analysis in the investigation of hemophilia a patients with very low levels of Factor VIII Activity (FVIII:C)","volume":"87","author":"T Matsumoto","year":"2002","journal-title":"Thromb Haemost"},{"issue":"2","key":"pone.0320111.ref015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1160\/TH11-05-0331","article-title":"A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies","volume":"107","author":"T Matsumoto","year":"2012","journal-title":"Thromb Haemost"},{"issue":"1","key":"pone.0320111.ref016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/a-2145-7139","article-title":"Characterization and usefulness of clot-fibrinolysis waveform analysis in critical care patients with enhanced or suppressed fibrinolysis","volume":"124","author":"T Tsuchida","year":"2024","journal-title":"Thromb Haemost"},{"issue":"6","key":"pone.0320111.ref017","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2000-13216","article-title":"Fibrin clot formation and lysis: basic mechanisms","volume":"26","author":"JJ Sidelmann","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"pone.0320111.ref018","article-title":"Basic mechanisms and regulation of fibrinolysis","author":"C Longstaff","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"pone.0320111.ref019","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"JC Chapin","year":"2015","journal-title":"Blood Rev"},{"issue":"4","key":"pone.0320111.ref020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/ijlh.13428","article-title":"Characterization of fibrin\/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis","volume":"43","author":"O Kumano","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"pone.0320111.ref021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0009-8981(01)00779-3","article-title":"A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma","volume":"318","author":"A Hamano","year":"2002","journal-title":"Clin Chim Acta"},{"key":"pone.0320111.ref022","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2007.07.023","article-title":"Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis","volume":"386","author":"M Ieko","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"4","key":"pone.0320111.ref023","first-page":"433","article-title":"Basic evaluation of the newly developed \u201cLias Auto P-FDP\u201d assay and the influence of Plasmin-\u03b12 Plasmin inhibitor complex values on discrepancy in the comparison with \u201cLias Auto D-Dimer Neo\u201d assay","volume":"64","author":"O Kumano","year":"2018","journal-title":"Clin Lab"},{"issue":"4","key":"pone.0320111.ref024","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jacasi.2023.06.004","article-title":"Coagulation biomarkers and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: ANAFIE subcohort study","volume":"3","author":"Y Koretsune","year":"2023","journal-title":"JACC Asia"},{"issue":"3","key":"pone.0320111.ref025","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13961","article-title":"Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII","volume":"26","author":"N Shimonishi","year":"2020","journal-title":"Haemophilia"},{"issue":"2","key":"pone.0320111.ref026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/rth2.12034","article-title":"Clot stability as a determinant of effective factor VIII replacement in hemophilia A","volume":"1","author":"L Leong","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"pone.0320111.ref027","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.CIR.79.3.666","article-title":"Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers","volume":"79","author":"CW Francis","year":"1989","journal-title":"Circulation"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T17:32:48Z","timestamp":1755538368000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0320111"}},"subtitle":[],"editor":[{"given":"Tomasz W.","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0320111","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}